<DOC>
	<DOCNO>NCT03069001</DOCNO>
	<brief_summary>This prospective study conduct Ain Shams University Hospital , Internal Medicine , Hepatology Gastroenterology Department , Tropical Medicine Department . To compare efficacy combination sofosbuvir simeprevir 12 week combination sofosbuvir ribavirin 24 week Egyptian patient HCV-related Child A cirrhosis .</brief_summary>
	<brief_title>Sofosbuvir Simeprevir Versus Sofosbuvir Ribavirin Treatment HCV</brief_title>
	<detailed_description />
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Patients chronic HCV infection positive HCV RNA level PCR . Total bilirubin &gt; 2 mg/dl . serum albumin &lt; 2.8 g/dl . INR &gt; 1.7. platelet count &lt; 50000/mm3 . serum creatinine &gt; 2.5 mg/dl . patient present ascites hepatic encephalopathy . patient evidence cause liver disease , include hepatitis A , hepatitis B , autoimmune hepatitis , alcoholic liver disease , druginduced hepatitis , haemochromatosis , Wilson disease alpha1 antitrypsin deficiency . patient advanced systemic disease . pregnancy inability use effective contraception female .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HCV treatment</keyword>
</DOC>